Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
Foli
A
A
Maserati
R
R
Minoli
L
L
Wainberg
M A
MA
Gallo
R C
RC
Lisziewicz
J
J
Lori
F
F
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D016049:Didanosine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D016049:Didanosine; D006918:Hydroxyurea